Oncology – Medxy AI

Deciphering the Role of Intratumoral Microbiota in Breast Cancer: Pathogenesis to Precision Therapeutics

By MedXY 09/30/2025

Intratumoral microbiota significantly influence breast cancer development, progression, and therapeutic response. Their diverse composition across subtypes presents diagnostic and prognostic opportunities. Emerging strategies target these microbes to improve treatment efficacy and overcome resistance.

Clinical Updates Oncology

Novel Heparanase Inhibitor LMW-DSS Shows Promise in Preventing Breast Cancer Metastasis by Targeting Migration and Angiogenesis

By MedXY 09/30/2025

Low-molecular-weight dextran sulfate sodium (LMW-DSS), a new heparanase inhibitor, effectively prevents breast cancer metastasis in mice by inhibiting cancer cell migration and angiogenesis, offering a promising therapeutic approach with minimal bleeding risk.

Clinical Updates Oncology

Advancing Immunotherapy in Head and Neck Cancer: A Curcumin-Based Polymer Prodrug Nanoplatform Targeting Cancer Stemness and Tumor Microenvironment

By MedXY 09/29/2025

A novel curcumin-based polymer prodrug nanoplatform enhances immunotherapy in head and neck cancer by targeting tumor cell stemness and reversing immunosuppression via synergistic photothermal, photodynamic, and ferroptosis mechanisms.

Oncology Specialties Wellness & Lifestyle

Alcohol and Pancreatic Cancer: Emerging Evidence of Risk

By MedXY 07/30/2025

New research strengthens the link between alcohol consumption and pancreatic cancer, highlighting both dose-dependent and threshold risks.

Clinical Updates Oncology Specialties Wellness & Lifestyle

Antibody-Drug Conjugates in Breast Cancer: Efficacy, Toxicity, and Evolving Management Strategies

By MedXY 07/30/2025

Antibody-drug conjugates (ADCs) have transformed breast cancer therapy but bring notable toxicity risks. This review examines the clinical evidence, adverse event management, and future directions for optimizing ADC use.

OB/GYN & Women's Health Oncology Specialties Wellness & Lifestyle

Understanding Hormone Therapy and Breast Cancer Risk in Younger Women

By MedXY 07/29/2025

Recent research highlights that estrogen-only hormone therapy may reduce breast cancer risk in women under 55, while combined estrogen-progestin therapy could increase risk.

Oncology Specialties Wellness & Lifestyle

Cervical Cancer Risk After 65: Why Continued Screening Matters

By MedXY 07/29/2025

Emerging research reveals heightened risk of cervical cancer in women aged 65 and older, driven by human papillomavirus (HPV). Continued screening is crucial to address increasing incidence and improve outcomes.

OB/GYN & Women's Health Oncology Specialties Wellness & Lifestyle

Advancing Access to Cervical Cancer Screening: The Promise of Self-Collection Methods

By MedXY 07/29/2025

Self-collection devices for cervical cancer screening offer a safe, effective, and preferred alternative to traditional methods, increasing accessibility and compliance.

OB/GYN & Women's Health Oncology Specialties Wellness & Lifestyle

Mail-in HPV Self-Tests Double Cervical Cancer Screening Rates

By MedXY 07/29/2025

Mail-in HPV self-collection kits significantly increase cervical cancer screening participation, offering a promising tool to enhance early detection and preventive care.

Oncology Specialties Wellness & Lifestyle

The Growing Role of Music Therapy in Cancer Rehabilitation: Science, Practice, and Patient Stories

By MedXY 07/26/2025

Music therapy is emerging as a promising approach in cancer recovery, easing symptoms, supporting mental health, and enhancing quality of life. Scientific evidence and practical recommendations reveal its growing value.

Medical News Oncology

AI-Designed Proteins Revolutionize Personalized Cancer Treatment

By MedXY 07/25/2025

AI-powered protein design offers a fast, personalized approach to cancer treatment, enhancing immune response and minimizing side effects.

Medical News Oncology Specialties

A New Era in Precision Cancer Therapy: AI-Designed Proteins Pave the Way for Personalized Treatment

By MedXY 07/24/2025

Researchers developed an AI platform designing proteins that direct immune cells to target cancer precisely, accelerating personalized immunotherapy from years to weeks. This breakthrough enables rapid, specific treatments, promising safer, adaptable cancer therapies, pending clinical trials to ensure efficacy and safety in patients.